Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Immunic Appoints Patrick Walsh as CBO; Joins from Akebia (2021-10-14)
Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases, announced the appointment of Patrick Walsh as Chief Business Offi...
VeroVaccines Closes Mid-7-figure € Series B Financing (2021-10-14)
> Vaccine specialist closes Mid-Seven-Figure Series B Financing Round > Shareholder group expanded by four new investors with important expertise > The fresh funding will be used to drive several vaccine programs into regulatory development Vaccine s...
Abalos Therapeutics Extends Series A with €32.5m to €43m (2021-10-14)
Additional EUR 32.5 million will support clinical readiness and accelerate lead immuno-virotherapy candidates toward clinical proof-of-concept Abalos Therapeutics announced today an extension to its Series A funding round bringing the total raised in this rou...
Rectify Pharmaceuticals Launches with $100m Series A (2021-10-14)
– Disease-modifying therapeutics for patients with genetic diseases caused by mutations in ABC transporters – Rectify Pharmaceuticals, Inc., (“Rectify”) a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics th...
Robert Fabregat Is New CEO of Biocat; Follows Jordi Naval (2021-10-14)
He is taking over the position held since 2018 by Jordi Naval, now CEO of InProTher. The Biocat Board of Trustees, chaired by President of the Government of Catalonia Pere Aragonès, has named Robert Fabregat the organization's new CEO. Fabregat is taking over...
European Circular Bioeconomy Fund Reaches €200m (2021-10-13)
> The European Circular Bioeconomy Fund (ECBF) promotes the development of a climate-neutral, resource-efficient economy and supports efforts to implement the European Green Deal > New financial investors as well as existing investors NRW.BANK, Volkswohl Bund an...
Kelly Services: Stéphane Miras New Director Life Sciences CH (2021-10-13)
Stéphane Miras is the new Director Life Sciences and member of the Swiss Leadership Team of Kelly Services (Switzerland) AG as of October 1, 2021. Kelly is considered one of the strongest players in the Life Sciences recruitment industry in Switzerland. Stéphane Mi...
Intellia Tx & SparingVision: Strategic CRISPR Collaboration (2021-10-13)
> Collaboration combines Intellia’s proprietary genome editing technology platform with SparingVision’s significant ophthalmology expertise > Intellia will grant SparingVision exclusive rights to its leading in vivo CRISPR/Cas9 technology for the development of ...
CureVac & GSK Withdraw EU Application for CVnCoV (2021-10-12)
> COVID-19 vaccine efforts to be re-allocated to accelerate the development of second-generation program in collaboration with GSK > First-generation vaccine candidate, CVnCoV, to be withdrawn from regulatory review due to potential overlap with approval timelin...
Idorsia’s Ph3 of Lucerastat in Fabry Disease Misses Endpoint (2021-10-11)
Ad hoc announcement pursuant to Art. 53 LR Idorsia Ltd (SIX: IDIA) today announced that MODIFY, the Phase 3 study to investigate the effect of lucerastat, as an oral substrate reduction therapy for the treatment of adult patients with Fabry disease, did not me...

» Show all News!

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture [iito] Made Without Love 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]